What is the recommended dose of calcitonin (CT) in a patient (pt) with a fracture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Calcitonin Dosage for Patients with Fractures

For patients with acute osteoporotic spinal compression fractures, calcitonin should be administered at a dose of 200 IU daily for 4 weeks, either as nasal spray (alternating nostrils daily) or as suppositories. 1

Dosing Recommendations by Route of Administration

Nasal Spray Administration

  • 200 IU (one spray) per day administered intranasally, alternating nostrils daily 2
  • The nasal spray bottle should be kept at room temperature between 20°C to 25°C (68°F to 77°F) in an upright position after opening 2
  • Prime the pump before first use by holding the bottle upright and depressing the pump until a full spray is emitted 2
  • Do not prime before each daily dose as this wastes medication 2

Parenteral Administration

  • 100 IU subcutaneously or intramuscularly every other day can be used as an alternative to nasal spray 1
  • For acute pain management in vertebral fractures, 50-100 IU daily subcutaneously has shown benefit 3

Duration of Treatment

  • For acute vertebral compression fractures: 4 weeks is the recommended initial treatment period 1
  • Pain relief typically occurs within the first 2 weeks and can continue for at least 4 months 3
  • For longer-term treatment in established osteoporosis, nasal calcitonin in a 2-month-on and 2-month-off fashion for up to 12 months has shown benefit 1

Clinical Benefits and Considerations

Pain Management

  • Calcitonin provides rapid onset and strong analgesic effect in patients with acute vertebral fractures 3, 4
  • Pain is significantly lower in the first week of treatment with salmon calcitonin (100-200 IU daily) compared to control groups 4
  • The number needed to treat for pain relief is approximately two patients 4

Bone Mineral Density Effects

  • Prolonged administration of nasal calcitonin at 200 IU daily can increase lumbar spine bone mineral density by 1.7%-3.3% after 1 year 5
  • The PROOF study demonstrated that 200 IU daily nasal calcitonin reduced the risk of new vertebral fractures by 33% 6

Specific Patient Populations

Osteoporotic Spinal Compression Fractures

  • Calcitonin should be initiated within 0-5 days after an identifiable event or onset of symptoms 1
  • Only use in neurologically intact patients 1

Postmenopausal Women

  • Calcitonin should be used only in women with less serious osteoporosis who cannot tolerate other treatments 1
  • In women more than five years past menopause, 200 IU daily nasal spray is the recommended dose 1

Patients with Hip Fractures

  • 200 IU salmon calcitonin nasal spray twice daily for 12 months has shown benefits in postmenopausal women following total hip arthroplasty 7
  • This regimen promotes independence, mobility, and reduces fear of falls 7

Side Effects and Contraindications

  • Side effects of calcitonin include mild dizziness 1
  • Nasal calcitonin is better tolerated than injectable forms, with side effects being rare and generally negligible 5
  • Contraindicated in patients with allergy to calcitonin-salmon or synthetic calcitonin-salmon 1

Combination Therapy

  • Calcium and vitamin D supplementation should be given concurrently with calcitonin therapy 1
  • For patients with established osteoporosis, combination therapy with 0.5 μg daily of calcitriol, 1.5 g of calcium, and calcitonin may improve bone density 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.